Sanofi India Aligns Manufacturing, Sheds Site To Zentiva

Sanofi sells Indian facility to Zentiva, a key customer for products made at the site, and hopes to make up for the earnings gap through a renewed push for its “core activities and brands.”

Trees
Sanofi's Long Term Strategy Is To Focus On Manufacturing Own Brands

Sanofi is divesting a core Indian manufacturing facility to Zentiva BV for about INR2.61bn ($36.5m), as the French group aligns towards a broader strategic thrust that includes making its own branded products.

Sanofi India Ltd, a locally listed subsidiary of the French multinational, said that it was making a slump sale and...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from India

More from Focus On Asia